Princess Elisabeth of Belgium's studies at Harvard University are now uncertain after the Trump administration's decision to revoke the uni...

For Pope Francis' funeral, seating arrangements prioritize Argentina and Italy, followed by other nations in French alphabetical order. Roy...

SMP Chairman P L Haranadh attributed the net surplus growth to higher cargo handling, cost-cut measures and reduction in the requirement fo...

Events where some of the richest people will make an appearance over the coming months.

Perhaps it was the dictum of St Benedict of Nursia - that monks should do manual labour to sustain themselves - which paved the way for the...

The year's biggest high society event in Paris for scions, le Bal, saw Gauravi Kumari of Jaipur's royal family among the 25 invitees.

A calendar for the high life in Europe, if you live it or decide to chase it this glamorous season.

The list, written in both English and Arabic, was uncovered by the media group Vocativ, which specialises in investigating the hidden side ...

As per the agreement, Glenmark has obtained semi-exclusive marketing and distribution rights of the product across 15 European countries

Jubilant Biosys will carry out research services and deliver preclinical candidates to Janssen for potential development and commercialisat...

"I would like my brand to outlive me," says Salman Khan at the launch of the first flagship store of Being Human in Mumbai's Bandra, well a...

King Farouk of Egypt, who was deposed in 1952 following a revolution, was once famously quoted as saying, “The whole world is in revolt."

Pharma firm Jubilant Life Sciences soared over 11% after its US-based arm inked drug discovery pact with Belgium-based Janssen Pharmaceutic...

Microsoft challenge to an 899 million-euro ($1.26 billion) EU penalty for failing to comply with an antitrust ruling may lead to a curb on ...

A globalising India can ill-afford to ignore the perils of disallowing tax credit.

With the global pharma companies cutting back on costs, letting go of people and shutting down plants in large markets, the crisis is palpa...

Alembic today said it has signed $11 million licensing agreement with Belgium-based UCB for anti-epileptic drug Keppra.